VPC-3033 is a potent androgen receptor antagonist that effectively inhibits androgen receptor transcriptional activity with an IC50 of 0.3 µM. This compound demonstrates significant degradation of the androgen receptor, enhancing its efficacy in therapeutic contexts. VPC-3033 is particularly valuable in research involving prostate cancer cells resistant to Enzalutamide, providing a critical tool for studying anti-androgen resistance mechanisms and developing novel treatment strategies.
VPC-3033 is a potent androgen receptor antagonist that effectively inhibits androgen receptor transcriptional activity with an IC50 of 0.3 µM. This compound demonstrates significant degradation of the androgen receptor, enhancing its efficacy in therapeutic contexts. VPC-3033 is particularly valuable in research involving prostate cancer cells resistant to Enzalutamide, providing a critical tool for studying anti-androgen resistance mechanisms and developing novel treatment strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
